ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Actuate Therapeutics Inc

Actuate Therapeutics Inc (ACTU)

8.61
-0.31
( -3.48% )
Updated: 06:02:03

Actuate Therapeutics Inc Financial Summary

The current ACTU market cap is 168.17M. The company's latest EPS is USD -1.2669 and P/E is -6.99.

Quarter End Mar 2024Jun 2024
USD (US$)
Total Revenue 00
Operating Income -7.77M-5.44M
Net Income -8.3M-6.57M
Year End 31 December 2023 2023
USD (US$)
Total Revenue 0
Operating Income -24.97M
Net Income -24.75M
Quarter End Mar 2024Jun 2024
USD (US$)
Total Assets 2.7M1.73M
Total Liabilities 16.3M21.81M
Total Equity -107.77M-114.26M
Year End 31 December 2023 2023
USD (US$)
Total Assets 3M
Total Liabilities 8.44M
Total Equity -99.63M
Quarter End Mar 2024Jun 2024
USD (US$)
Operating -5.25M-7.92M
Investing N/A N/A
Financing 4.36M5.31M
Year End 31 December 2023 2023
USD (US$)
Operating -21.63M
Investing N/A
Financing 4.14M
Market Cap 168.17M
Price to Earnings Ratio -6.99
Price to Sales Ratio 0
Price to Cash Ratio 58.48
Price to Book Ratio -31.76
Dividend Yield -

Share Statistics

Shares Outstanding 19.53M
Average Volume (1 week) 51.24k
Average Volume (1 Month) 56.04k
52 Week Change 72.20%
52 Week High 10.162
52 Week Low 5.00
Spread (Intraday) 0.29 (3.29%)

Company Info

Company Name Actuate Therapeutics Inc
Address 108 lakeland ave
dover, delaware 19901
Website https://www.actuatetherapeutics.com
Industry pharmaceutical preparations (2834)